N@N

Olivia Brayer Reiterated (ALNY) at Hold and Held Target at $165 on, Dec 14th, 2023

^{Published on 2024-10-28 08:00:46 - WOPRAI, Olivia Brayer}
 

Olivia Brayer of Cantor Fitzgerald, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold and Held Target at $165 on, Dec 14th, 2023.

Olivia has made no other calls on ALNY in the last 4 months.

There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 3 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Tiago Fauth of "Wells Fargo" Initiated at Hold and Held Target at $171 on, Friday, December 8th, 2023
• Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $183 on, Friday, November 3rd, 2023
• Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, October 11th, 2023

These are the ratings of the 7 analyists that currently disagree with Olivia

---

• Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $395 on, Wednesday, November 15th, 2023
• Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $230 on, Friday, November 3rd, 2023
• David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $233 on, Tuesday, October 10th, 2023
• Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $234 on, Tuesday, October 10th, 2023
• Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $200 on, Monday, October 9th, 2023
• Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $208 on, Friday, September 29th, 2023
• Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023

Contributing Sources

---